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Abstract 
Candida albicans is the most prevalent human fungal pathogen. Unfortunately, there 
still remains much that is unknown about it, including the reason for maintaining a 
diploid genome and the function of many genes. In this thesis I describe the phenotypic 
consequences of up and downregulating Pseudouridine Synthase 4 (PUS4) of C. 
albicans, as well as an ex~mination of the differences in the expression level of the 
entire transcriptome. These experiments and resulting bioinformatic analysis have lead 
to our conclusion that that PUS4A is more lowly transcribed than PUS4B. This data 
suggests PUS4A may be nonfunctional or play a different role in C. albicans biology. 
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Process Analysis Statement 
My main goal for this thesis project was to conduct basic scientific research in the 
hopes of answering a simple question: do the two copies of the gene for Pseudouridine 
Synthase 4 in the fungal pathogen Candida albicans result in proteins with different 
functions? While this research was trying to answer a relatively simple question, it was 
also used to examine a more important question: Why does Candida albicans maintain 
a diploid genome? Understanding the importance of having two slightly different copies 
of one specific gene will give us a better understanding of the reason for having two 
copies of every gene. To examine these questions, I created two mutant strains that 
allowed me to increase or decrease the expression level of either copy of the gene, 
depending on what type of media they were grown on. These mutants allow me to 
examine what changes happen to the yeast as I change the expression level of either 
copy of Pseudouridine Synthase 4 (PUS4). I also used bioinformatics tools to examine 
sequence differences between the alleles. 
The process of conducting this thesis research, as well as the two years of 
research that lead up to it, taught me a lot about how to conduct scientific research. Not 
only did I learn how to design and conduct experiments, I also learned how to think like 
a scientist. This was most recently shown when our mRNA sequencing revealed new 
information about the expression level of expression of either allele of Candida a/bicans 
PUS4A and PUS48. I had to take the new data and figure out how it lined up with the 
rest of the data that I had collected. The new data prompted me to conduct another 
bioinformatics analysis, which in turn revealed data that helps to make sense of all of 
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our previous results. If I hadn't been able to understand how the sequencing data fit with 
the rests of my experiments, I likely wouldn't have come to the proper conclusions. 
Through the process of conducting research leading up to and during my thesis I 
also had to deal with the failure that is associated with conducting scientific 
experiments. The first year that I spent in the Bernstein lab I tried and failed to make a 
knockout of each allele of PUS4 using the CRISPR/Cas9 system. I had to learn how to 
deal with experiments failing over and over, and come up with possible explanations for 
the failure, both experimentally and biologically. Along with the failures though, I also 
learned that sometimes the failures can be informative as well. Using the knowledge 
that I learned from sequencing and bioinformatics analysis I was able to draw 
conclusions about why my initial experiments did not work. 
My results also taught me the importance of continuing to read the r~levant 
literature. Reading more literature about Candida a/bicans was critical to putting 
together the information to make proper conclusions. Learning about the 
haploinsufficency of PUS4 in Candida albicans was a major indicator that the two alleles 
did not have the same expression level and function , and helped to indicate that I 
should conduct another bioinformatics analysis. If I hadn't continued to read and learn 
about Candida a/bicans I likely wouldn't have had some of the breakthroughs I did. 
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Identification of allele specific function of Candida albicans Pseudouridine 
Synthase 4 
Introduction 
Candida albicans is the most prevalent human fungal pathogen, causing a 
variety of diseases including thrush, vaginal candidiasis, and invasive candidiasis 
(Kullberg and Arendrup, 2015). Invasive candidiasis alone causes 46,000 infections in 
the US every year, and has a mortality rate as high as 30% (CDC, 2013). As C. albicans 
strains are becoming increasingly resistant to antifungal drugs it becomes ever more 
important that we understand this organism at a molecular level. 
Though it is a clinically relevant organism, much of the inner workings of Candida 
a/bicans remain a mystery. While a sequenced genome of C. albicans exists, many 
open reading frames (ORFs) are not annotated (Skrzypek et al., 2017). Additionally, 
many of the annotations that are present are based upon orthology to Saccharomyces 
cerevisiae. S. cerevisiae is a genetic relative of C. albicans, both are members of the 
order Endomycetales. However, they vary massively in key phenotypes, including 
environmental niche and pathogenesis (Oh et al., 2010). The differences between the 
two organisms makes inference of protein function through sequence analysis 
challenging. 
Further contributing to the difficulty of understanding Candida albicans is that it 
contains a diploid genome. While it does rarely exist in a haploid state, C. albicans is 
regarded as an obligate diploid (Hickman et al., 2013). Almost all clinical isolates and 
laboratory strains, including the most common laboratory strain SC5314, have a diploid 
genome (Skrzypek et al., 2017). Furthermore, haploids quickly revert to a diploid state. 
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A 
Therefore, it is important that we reach a better understanding of why C. albicans 
maintains the diploid state. 
One avenue of exploration is the allelic difference that are present in many ORFs 
in Candida albicans, including Pseudouridine Synthase 4 (PUS4) (Skrzypek et al., 
2017). Most of our knowledge of the molecular function of C. albicans Pseudouridine 
Synthase 4 comes from its S. cerevisiae ortholog. InS. cerevisiae PUS4 encodes a 
pseudouridine synthase that catalyzes the formation of pseudouridine from uridine at 
residue 55 of tRNAs (Figure 1) (Becker et al., 1997). It operates on both cytoplasmic 
and mitochondrial tRNAs, as well as a less well understood role in modifying mRNA 
(Schwartz et al., 2014). 
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Figure 1: A) A diagram showing the process of pseudouridylation. Adapted from (Zhao 
et al., 2018). B) A sequence map of yeast tRNA showing the pseudouridine at residue 
55 caused by Pus4. 
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Candida albicans Pus4 is believed to have the same functions as S. cerevisiae 
Pus4 (Skrzypek et al., 2017). However, the two alleles of PUS4 have differences in 
sequence. The 13 nucleic acid differences results in 6 amino acid differences between 
the two proteins. Additionally, it is known that PUS4 is haploinsufficent (Oh et al., 201 0). 
These two facts lead to our hypothesis that the two alleles of C. albicans PUS4 results 
in proteins with different functions. To test this I am examining the phenotypic 
consequences of knocking down or overexpressing either the A or B allele, as well as a 
examining the consequences on the C. albicans transcriptome during either A or B 
allele knockdown. 
Methods 
The maltose promoter 
A maltose inducible promoter, pV811 , was introduced immediately upstream of 
either the A or the B allele of PUS4 using homologous recombination. The promoter 
upregulates transcription of the allele when it is grown on maltose and reduces 
transcription when grown on glucose. The promoter construct also conveys resistance 
to nourseothricin, allowing for screening of our transformed mutants. After purifying the 
promoter plasmid, PCR was conducted using primers with 40bp of homology to the 
PUS4 allele and 20bp homology to the promoter (Appendix 1 ). This product was 
transformed into Candida albicans and transformation success was screened using 
nourseothricin. The proper insertion of the promoter was verified by PCR and 
sequencing. Strains with properly inserted promoter were saved at -80°C in a glycerol 
stock, and grown from the stock for every experiment (Appendix 2). 
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Oligomycin resistance and tolerance 
The resistance and tolerance assay was conducted using a standard drug 
diffusion assay, with 100ng of Oligomycin being used on each plate. The plates were 
analyzed using the R package DisklmageR, and the resistance and tolerance was 
determined using a 50% reduction in growth (Gerstein et al., 2016). 
Virulence trials 
To examine C. albicans virulence Galleria melonella, wax moth larvae, were 
used as a model organism. For the virulence trials 100 of yeast cells were spun at 
5,000 RPM for 5 minutes in an centrifuge. The pellets were washed with 1 ml PBS, and 
then were spun again . The pellets were suspended in 1ml PBS and 101-11 (1x105 cells) 
were injected into the second to last proleg of a larva. The worms were placed at 3TC 
and monitored for death every day for up to 12 days. The survival chart was visualized 
using the SurvMiner package in R. 
mRNA sequencing 
The total RNA was extracted by hot acid phenol from wildtype SC5314, and the 
PUS4A and PUS4B knockdown strains. Four replicates of each strain were polyA 
selected and sequenced by GeneWiz, a Next Generation Sequencing company. The 
reads were then mapped to the Candida albicans genome, and expression was 
compared to identify significant changes in gene expression between strains. 
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Results 
Growth and filamentation assays 
The growth rate of CE17, which contains the maltose promoter upstream of 
PUS4A, and CE16, which contains the maltose promoter upstream of PUS4B, were 
compared to wildtype Candida albicans, SC5314 on media containing glucose and 
maltose. We did not see any difference between wildtype and the knockdown strains 
that were grown on glucose (Figure 2). We did see that all of the yeast grown with 
maltose as a carbon source grew slower than the ones on glucose. However, when 
comparing the maltose overexpression strains to SC5314 grown on maltose, there was 
no difference in growth. This result suggests that Pus4 does not have a significant effect 
on growth. 
SC5314 on glucose 
PUS4A Knockdown 
SC5314 on maltose 
PUS4A Overexpression 
PU$48 Overexpression ... -.~~~..~ 
Figure 2: Growth assay conducted on YPD and YPmaltose at 3o·c, grown for 2 days. 
There was no difference in growth when the wildtype and strains with altered PUS4 
expression. 
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Oligomycin Resistance Analysis 
S. cerevisiae Pus4 is critical for pseudouridylation of mitochondrial tRNAs, and 
the same function is inferred for Candida albicans Pus4. To determine how changes in 
PUS4 expression affects the ability of the cell to survive with impaired mitochondria 
function we tested our mutants' resistance and tolerance to Oligomycin, an electron 
transport chain inhibitor, by disk diffusion assay. Resistance is the distance from the 
edge of the drug disk to where a 50% reduction in growth occurs. Tolerance is based 
upon the amount of cells that are growing beyond the 50% reduction in growth. There is 
no difference when looking at the resistance of either the knockdown or overexpression 
strains (Figure 3A). However, there was a reduction in tolerance when any of the yeast 
were grown on maltose. Furthermore, when compared to SC5314 that was grown on 
maltose, overexpressing both PUS4A and PUS4B had decreased tolerance to 
oligomycin. Additionally, reducing expression of PUS4B results in an increased 
tolerance to oligomycin (Figure 38). These results suggest a possible role of Pus4 in 
mitochondrial function . Upregulating PUS4B increases tolerance to mitochondrial 
dysfunction, which indicates a possible change in transcription when the cell is forced to 
perform fermentation instead of respiration. 
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Figure 3: A) The resistance to oligomycin based on a 50% reduction in growth. There is 
no difference between resistance to oligomycin when the expression level of PUS4 is 
changed. B) The tolerance to oligomycin calculated based on a 50% reduction in 
growth. The PUS4B knockdown had increased tolerance when compared to wild type, 
and reducing the expression of PUS4 results in decreased tolerance to oligomycin. 
Virulence Assay 
As Candida albicans is a human pathogen, it is critical to determine if changes in 
PUS4 expression results in a change in virulence. The virulence of the mutant strains 
was tested by injecting Galleria melonella with Candida albicans. G. melonella are well 
characterized models for Candida albicans virulence, and have a similar innate immune 
system to mammals (Brennan et al., 2002). No difference was detected between the 
virulence of wild type C. a/bicans and strains with changes in PUS4 expression (Figure 
4). These results indicate that Pus4 doesn't play a role in virulence. 
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Figure 4: A survival chart showing the death of Galleria melonella larvae over a period 
of days. There was no difference in the survival of worms injected with wildtype Candida 
albicans or with strains that had changes in PUS4 expression. 
mRNA sequencing 
To determine how a knockdown of the A orB allele of PUS4 effects the 
expression of other genes, we sequenced the transcriptome of the two knockdown 
strains and wildtype Candida a/bicans. Because there are only 13 differences between 
the DNA sequences of PUS4A and PUS48, most reads map nonspecifically to either 
allele (Skrzypek et al. , 2017). Mapping reads to the genome indicates that knocking 
down PUS4A results in a negligible change in reads that map to PUS4. However, 
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knocking down PUS4B sees a large reduction in transcripts that map to PUS4 (Figure 
5). Our results suggest only PUS4B is expressed. Using a maltose promoter to 
knockdown PUS4A likely does not change the expression level because it is not 
expressed. 
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Figure 5: A) The average number of reads from RNA sequencing that mapped to 
PUS4A from the knockdown and wildtype strains. Only the PUS4B knockdown resulted 
in a significant decrease in expression. B) The average number of reads from RNA 
sequencing that map to PUS4B from the knockdown and wildtype strains. Only the 
PUS4B knockdown resulted in a decrease in expression. 
Bioinformatic analysis 
Based on the previous results we conducted a bioinformatic analysis of the 
sequence of Pus4. The most notable difference between the two proteins is a mutation 
at residue 175 of Pus4 (Skrzypek et al. , 2017). In PUS4B there is a proline residue at 
this position, but in PUS4A it has changed to a serine. Furthermore, this proline residue 
is very highly conserved , appearing in the Pus4 ortholog in eight closely related 
Candida species, Saccharomyces cerevisiae, as well as many other yeast species that 
are not closely related (Figure 6). Proline is a structurally important amino acid, and it's 
conservation at this residue suggests it plays an important role in Pus4 function (Deber 
et al., 201 0). We hypothesize the mutation from proline to serine disrupts the structure 
of Pus4A, rendering it nonfunctional. Additionally, we examined the promoter sequence 
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upstream of both alleles and found there were differences in sequence. One of these 
differences introduces an Aft2 binding site at residue -99 upstream of the B allele but 
not the A allele. (Appendix 3) (Teixeira et al. , 2018). Additionally, there is a second 
binding site for Mot3 upstream of PUS4A that is not present in PUS4B (Appendix 3). 
Aft2p is an iron dependent transcriptional activator that has been shown to have a role 
in C. albicans morphogenesis and virulence (Liang et al. , 2010). Mot3 is a 
transcriptional repressor that can play a role in filamentation (Khalaf and Zitomer, 2001 ). 
Together these results suggest a biological mechanism for decreased expression of 
PUS4A. The lack of a binding site for an activator and an extra site of a repressor likely 
turns off expression of PUS4A so that a non-functional protein is not produced. 
* C. albicans A .PL YEYARKGLSLPTN 
C. a/bicans B PL YEYARKGLPLPTN 
5. cerevisiae.PLHEYAREGKPLPRA 
N. crassa PL YEYAREGKPI PRE 
F. graminearum PL YEYAREGKPI PRQ 
C. neoformans.PL YEYARESKPLPRP 
U. maydis.RLFEYARENLPLPRP 
5. pombe.RL YEYAREGI PLPES 
Figure 6: The mutation of proline to serine at residue 175 in Candida albicans PUS4A. 
The proline residue is conserved in almost all yeast species, including the species of 
note shown here. 
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Discussion 
For much of our experiments, including the growth assay, we did not see a 
difference when the expression of one PUS4 allele was changed. The lack of a 
difference suggests that Pus4 does not have a direct impact on growth rate, though this 
should be further explored. Though we did see a small difference in tolerance to 
oligomycin, it was small. This is likely because Candida albicans can survive without it's 
mitochondria, switching to fermentation for energy (Shingu-Vazquez and Traven, 2011 ). 
The ability to rely on fermentation likely prevents the mitochondrial dysfunction caused 
by oligomycin from having a larger impact on growth, which would make the change in 
tolerance more notable. Additionally we did not see a difference in virulence in Galleria 
mellonella in any of the strains. Because neither the increase or decrease in expression 
of PUS4 results in a change in virulence it suggests that pathogenesis is not dependent 
upon precise levels of Pus4 in a cell. 
Our sequencing results and further bioinformatic analysis help to explain the 
modest changes that we see in our phenotypic assays. The maltose promoter inserted 
upstream of PUS4A likely had little to no effect on expression because the allele is not 
expressed or expressed at very low levels normally. When we did see some small 
changes in phenotype, such as in the tolerance to oligomycin, they were as a result in 
changing the expression of PUS4B. This is because only the expression of PUS4B is 
changing. While our experiments helped to confirm some of the functions of Pus4 that 
were inferred from Saccharomyces cerevisiae more work should be done to verify 
functions of Pus4 in Candida albicans. This work should focus on PUS4B. 
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Combining our data from sequencing and the bioinformatic analysis allows us to 
propose a hypothesis for the elimination of transcription from PUS4A. We propose that 
the proline residue mutated to a serine residue, which rendered the protein 
nonfunctional. A nonfunctional Pus4A was no longer under pressure to be transcribed 
and this allowed a mutation in the binding site for Aft2p to occur without consequence, 
eliminating transcription of the faulty protein. In addition, one could posit that a 
nonfunction Pus4A could act a dominant negative and actually be harmful to the cells in 
which case turning off expression would be beneficial. This data also leads to a 
potential answer to the question of why Candida albicans maintains a diploid genome. 
Having two copies of the PUS4 gene allowed the organism to compensate for mutations 
that lead to a loss of function. In this way the diploid genome can be used as a way for 
Candida albicans to compensate for mutations without a significant loss of function. This 
hypothesis can also help explain why haploid Candida albicans is less fit than diploid 
strains (Hickman et al. , 2013), because they do not have the ability to compensate for 
mutations. Additionally, even though haploid Candida albicans can revert to diploid, it 
generates a homozygous diploid. If one allele of a gene, such as PUS4A, contained a 
mutation that resulted in a less or non-functional protein, a homozygous diploid might 
have two copies of that allele that leads to a negative effect, rendering it less fit. 
In the future more work should be done to better classify the functions of Pus4B, 
particularly in conditions similar to infection. Furthermore, since Aft2p is an iron-
dependent transcription factor, the influence of different iron concentrations on the 
expression of PUS4B and the function of Pus4B should be explored. Additionally, the 
targets of Pus4B should be determined, particularly the relatively unknown mRNA 
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targets. Better understanding of the functions of Pus4B will help further the 
understanding of both the role of pseudouridylation in Candida albicans and the 
pressure to maintain a diploid genome. 
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Appendix 1: Oligos used in this study 
Description Allele Sequence 5'-3' 
Maltose promoter forward transformation guide PUS4A gatgtcgcactaccacacgcaatagaaaaatagaatcctggtaccgaattcgagctcgtt 
Maltose promoter reverse transformation guide PUS4A accactgcaaaaagttggggatgtaatgcctgagggtttgtatactgcaaatactccgtt 
Maltose promoter sequencing primer Both atgagtgatgatgtcgcact 
Maltose promoter forward transformation guide PUS4B gatttcgcactaccacacccaatagaaaaatagaaacctggtaccgaattcgagctcgtt 
Maltose promoter reverse transformation guide PUS4B accactgcaaaaagttggggatgtaatgcctgagggtttgtatactgcaaatactccgtt 
Sequences that are complementary to the maltose promoter are shown in bold, while 
sequences that are complementary to Candida albicans are shown in regular font. 
Appendix 2: Strains used in this study 
Strain ID Alternate Strain ID Organism Description 
CE1 DAB 690 Candida albicans SC5314, Wildtype 
CE16 DAB 801 Candida albicans Maltose inducible promoter 
upstream of PUS4B 
CE17 DAB 802 Candida albicans Maltose inducible promoter 
upstream of PUS4A 
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Appendix 3: Transcription factors upstream of PUS4A and PUS48 
[Transcription Factor Binding Site !Consensus Sequence BP Upstream of PUS4 A 
~sh1 ~TGAT 349 
~sh1 IYTGAT 336 
. ~sh1 ~TGAT 313 
~sh1 rt'TGAT 196 
~sh1 ~TGAT 145 
~zf1 AAAAGAAA 380 
~zf1 ~GAAA 325 
Basf1,Gcn4 [TGACTC 283 
Fkh1,Fkh2 RYMAAYA 308 
Fkh1,Fkh2 RYMAAYA 272 
Fkh1,Fkh2 RYMAAYA 44 
Gcn4 [TGATTCA 498 
Gcn4 ifGATTMA 284 
Gcn4 RRTGACTC .281 
Gcr1 CWTCC 1461 
Gcr1 CWTCC 155 
Mac1 TTTGCKCR 1467 
Mot3 CAGGYA 1468 
Mot3 TMGGAA 1416 
Mot3 AAGGWT 174 
Rtg1, Rtg3 GTCAC ~87 
Stb5 CGGNS ~90 
Stp2 CNCACCNG 1425 
P<bp1 CTCGA 1458 
IYap1, Cad1, Yap3, Cin5, Yap5 TTACTAA 393 
IYap1 TKACAAA 385 
IYap1 ITTACTCA 215 
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~ranscription Factor Binding Site Consensus Sequence BP Upstream of PUS4 B 
~ft2, Aft1 IYRCACCCR ~9 
fA,sh1 [YTGAT 350 
fA,sh 1 [YTGAT 337 
fA,sh1 [YTGAT . 314 
fA,sh1 [YTGAT 195 
Ash1 [YTGAT 144 
Azf1 ~GAAA 381 
Azf1 'AAAAGAAA 326 
Basf1,Gcn4 ~GACTC 284 
Fkh1,Fkh2 RYMAAYA 309 
Fkh1,Fkh2 RYMAAYA 272 
Fkh1,Fkh2 RYMAAYA 44 
Gcn4 ~GATTCA 498 
Gcn4 rrGATTMA 284 
Gcn4 RRTGACTC 282 
Gcr1 CWTCC 1462 
Gcr1 CWTCC 154 
Mac1 TTTGCKCR 1468 
Mot3 CAGGYA 1469 
Mot3 AAGGWT 173 
Rtg1, Rtg3 GTCAC 288 
Stb5 CGGNS 1291 
Stp2 CNCACCNG 1426 
Xbp1 CTCGA 1459 
Yap1 , Cad1, Yap3, Cin5, YapS TTACTAA 394 
[Yap1 TKACAAA 386 
l'fap1 TTACTCA ~14 
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